Roivant Sciences (ROIV) Other Working Capital Changes (2020 - 2026)
Roivant Sciences' (ROIV) quarterly Other Working Capital Changes came in at -$2.1 million in Q4 2025, up 61.35% YoY from -$1.3 million in Q4 2024, and down 165.83% on a QoQ basis from $3.2 million in Q3 2025.
Analysis
Roivant Sciences (ROIV) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Roivant Sciences (ROIV) has 6 years of Other Working Capital Changes data on file, last reported at -$2.1 million in Q4 2025.
- Quarterly Other Working Capital Changes rose 61.35% year-over-year to -$2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.3 million (up 91.56% YoY) and the FY2026 annual result came in at -$2.4 million, up 58.16% from the prior year.
- Other Working Capital Changes fell to -$2.1 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $53.9 million in Q4 2024 to a low of -$4.1 million in Q3 2024.
- A 5-year average of $13.2 million and a median of $11.3 million in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 1156.31% — and 2024, when it jumped 170.26%.
- Tracing ROIV's Other Working Capital Changes over 5 years: stood at -$6.2 million in 2021, then surged by 45.84% to -$3.3 million in 2022, then tumbled by 1156.31% to -$42.0 million in 2023, then jumped by 87.0% to -$5.5 million in 2024, then soared by 61.35% to -$2.1 million in 2025.
- The last three Other Working Capital Changes figures came in at -$2.1 million (Q4 2025), $3.2 million (Q3 2025), and $71000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 25.18 Bn | 25.18 Bn | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -286,000.00 |
| Jun 30, 2026 | -286,000.00 |
| Dec 31, 2025 | -2.11 Mn |
| Dec 31, 2025 | -2.11 Mn |
| Sep 30, 2025 | -846,000.00 |
| Sep 30, 2025 | -846,000.00 |
| Jun 30, 2025 | -478,000.00 |
| Jun 30, 2025 | -478,000.00 |
| Dec 31, 2024 | -5.46 Mn |
| Dec 31, 2024 | -5.46 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Dec 31, 2023 | -6.15 Mn |
| Dec 31, 2023 | -6.15 Mn |
| Sep 30, 2023 | -2.15 Mn |
| Sep 30, 2023 | -2.15 Mn |
| Jun 30, 2023 | -2.01 Mn |
| Jun 30, 2023 | -2.01 Mn |